US 8278450
Kinase inhibitors
granted A61PA61P19/02A61P25/00
Quick answer
US patent 8278450 (Kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P19/02, A61P25/00, A61P25/16, A61P25/28